ENNATURE BIO PHARMA LTD (ENNATURE) financials
ENNATURE BIO PHARMA LTD (ENNATURE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
ENNATURE BIO PHARMA LTD (ENNATURE) financials: Market Cap ₹375Cr., Price ₹168, P/E 49.3, ROE %. Sep 2026: sales ₹78.46 Cr, net profit ₹4.89 Cr. Quarterly resul…
- Market Cap: ₹375Cr.
- Current Price: ₹168
- Stock P/E: 49.3
- ROE: %
- ROCE: %
- Book Value: ₹
- Dividend Yield: 0.00%
- 52W High / Low: ₹275/165
In Sep 2026, ENNATURE BIO PHARMA LTD (ENNATURE) reported sales ₹78.46 Cr and net profit ₹4.89 Cr.
Annual Mar 2026: sales ₹246 Cr, net profit ₹1 Cr.
Shareholding: Promoters 59.63% (Nov 2026), FIIs 2.44% (Nov 2026), DIIs 4.61% (Nov 2026), Public 33.33% (Nov 2026), No. of Shareholders 48,292% (Nov 2026).
| Category | Sep 2025 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Sales | 54.14 | 90.39 | 78.46 |
| YoY Sales growth | — | — | +44.92% |
| Expenses | 48.10 | 80.40 | 68.12 |
| Operating Profit | 6.04 | 9.99 | 10.34 |
| OPM % | 11.16% | 11.05% | 13.18% |
| Other Income | 0.00 | 0.00 | 0.00 |
| Interest | 3.79 | 0.04 | 0.03 |
| Depreciation | 3.61 | 3.70 | 3.70 |
| Profit before tax | -1.36 | 6.25 | 6.61 |
| Tax % | -5.88% | 25.44% | 26.17% |
| Net Profit | -1.28 | 4.66 | 4.89 |
| EPS in Rs | -640.00 | 2,330.00 | 2.19 |
| Raw PDF | — | — | — |
| Category | Mar 2026 |
|---|---|
| Sales | 246 |
| Sales growth | — |
| Expenses | 217 |
| Operating Profit | 29 |
| OPM % | 12% |
| Other Income | -0 |
| Interest | 13 |
| Depreciation | 14 |
| Profit before tax | 2 |
| Tax % | 23% |
| Net Profit | 1 |
| EPS in Rs | 605.00 |
| Dividend Payout % | 0% |
| Category | Sep 2026 |
|---|---|
| Equity Capital | 11 |
| Reserves | 521 |
| Borrowings | 0 |
| Other Liabilities | 173 |
| Total Liabilities | 705 |
| Fixed Assets | 537 |
| CWIP | 11 |
| Investments | 0 |
| Other Assets | 157 |
| Total Assets | 705 |
| Category | Mar 2026 |
|---|---|
| Cash from Operating Activity | — |
| Cash from Investing Activity | — |
| Cash from Financing Activity | — |
| Net Cash Flow | — |
| Free Cash Flow | — |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | — |
| Category | Nov 2026 |
|---|---|
| Promoters | 59.63% |
| FIIs | 2.44% |
| DIIs | 4.61% |
| Public | 33.33% |
| No. of Shareholders | 48,292 |
| Category | Mar 2026 |
|---|---|
| Debtor Days | — |
| Inventory Days | — |
| Days Payable | — |
| Cash Conversion Cycle | — |
| Working Capital Days | — |
| ROCE % | — |
Ennature Bio Pharma Ltd
₹375Cr.
₹168
₹275/165
49.3
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of ENNATURE BIO PHARMA LTD (ENNATURE)?
The reported market capitalisation for ENNATURE BIO PHARMA LTD (ENNATURE) is ₹375Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of ENNATURE?
The current price shown for ENNATURE BIO PHARMA LTD (ENNATURE) on Fincrux is ₹168 with a 52-week high/low of ₹275/165.
What is the P/E ratio of ENNATURE BIO PHARMA LTD (ENNATURE)?
The stock P/E for ENNATURE BIO PHARMA LTD (ENNATURE) is 49.3 on Fincrux, with ROE at % and ROCE at %.
What were ENNATURE latest quarterly results?
For Sep 2026, ENNATURE BIO PHARMA LTD (ENNATURE) reported sales ₹78.46 Cr and net profit ₹4.89 Cr (figures in ₹ crore unless noted).
What are ENNATURE annual sales and net profit?
For Mar 2026, ENNATURE BIO PHARMA LTD (ENNATURE) shows sales of ₹246 Cr and net profit of ₹1 Cr on the Fincrux profit & loss statement.
Who owns ENNATURE BIO PHARMA LTD (ENNATURE)?
Latest shareholding for ENNATURE BIO PHARMA LTD (ENNATURE) on Fincrux: Promoters 59.63% (Nov 2026), FIIs 2.44% (Nov 2026), DIIs 4.61% (Nov 2026), Public 33.33% (Nov 2026), No. of Shareholders 48,292% (Nov 2026).
Where can I find ENNATURE BIO PHARMA LTD (ENNATURE) financials?
ENNATURE BIO PHARMA LTD (ENNATURE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show ENNATURE balance sheet and cash flow?
Yes. The ENNATURE BIO PHARMA LTD (ENNATURE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.